Cargando…

Distribution of Gene Mutations Associated with Familial Normosmic Idiopathic Hypogonadotropic Hypogonadism

Objective: Normosmic idiopathic hypogonadotropic hypogonadism (nIHH) is characterized by failure of initiation or maintenance of puberty due to insufficient gonadotropin release, which is not associated with anosmia/hyposmia. The objective of this study was to determine the distribution of causative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gürbüz, Fatih, Kotan, L. Damla, Mengen, Eda, Şıklar, Zeynep, Berberoğlu, Merih, Dökmetaş, Sebila, Kılıçlı, Mehmet Fatih, Güven, Ayla, Kirel, Birgül, Saka, Nurçin, Poyrazoğlu, Şükran, Cesur, Yaşar, Doğan, Murat, Özen, Samim, Özbek, Mehmet Nuri, Demirbilek, Hüseyin, Kekil, M. Burcu, Temiz, Fatih, Önenli Mungan, Neslihan, Yüksel, Bilgin, Topaloğlu, Ali Kemal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459159/ https://www.ncbi.nlm.nih.gov/pubmed/22766261 http://dx.doi.org/10.4274/Jcrpe.725

Ejemplares similares

GNRHR biallelic and digenic mutations in patients with normosmic congenital hypogonadotropic hypogonadism
por: Gonçalves, Catarina I, et al.
Publicado: (2017)

Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations
por: Akkuş, Gamze, et al.
Publicado: (2017)

Idiopathic Hypogonadotropic Hypogonadism Caused by Inactivating Mutations in SRA1
por: Kotan, Leman Damla, et al.
Publicado: (2016)

Dizygotic twin sisters with normosmic idiopathic hypogonadotropic hypogonadism caused by an FGFR1 gene variant
por: Choe, Jaewon, et al.
Publicado: (2020)

Normosmic idiopathic hypogonadotropic hypogonadism due to a novel GNRH1 variant in two siblings
por: Sagi, Satyanarayana V, et al.
Publicado: (2020)

Clinical, endocrinological, and molecular genetic characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism in childhood and adolescence
por: Shin, Sun-Jeong, et al.
Publicado: (2015)

Ecthyma gangrenosum in a previously healthy pediatric patient and associated facial paralysis and persistent hyperplastic primary vitreous
por: Bucak, Ibrahim Hakan, et al.
Publicado: (2012)

Clinical Characteristics of 46,XX Males with Congenital Adrenal Hyperplasia
por: Savaş-Erdeve, Şenay, et al.
Publicado: (2021)

Clinical, endocrinological, and molecular characterization of Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: a single center experience
por: Shin, Sun-Jeong, et al.
Publicado: (2015)

Posttranslational Modification Defects in Fibroblast Growth Factor Receptor 1 as a Reason for Normosmic Isolated Hypogonadotropic Hypogonadism
por: Ying, Hui, et al.
Publicado: (2020)

Evaluation of Permanent Growth Hormone Deficiency (GHD) in Young Adults with Childhood Onset GHD: A multicenter study
por: Berberoğlu, Merih, et al.
Publicado: (2008)

Normosmic Congenital Hypogonadotropic Hypogonadism Due to TAC3/TACR3 Mutations: Characterization of Neuroendocrine Phenotypes and Novel Mutations
por: Francou, Bruno, et al.
Publicado: (2011)

Mutation spectrum and frequency of copy number variations of the ANOS1 gene in patients with Kallmann syndrome or normosmic isolated hypogonadotropic hypogonadism
por: Hye Kim, Ja, et al.
Publicado: (2023)

Corrigendum to “Seminal plasma metabolomics signatures of normosmic congenital hypogonadotropic hypogonadism” [Heliyon 9(4) (March 2023) e14779]()
por: Li, Xiaogang, et al.
Publicado: (2023)

Bone Mineral Density in Adolescent Girls with Hypogonadotropic and Hypergonadotropic Hypogonadism
por: Özbek, Mehmet Nuri, et al.
Publicado: (2016)

Syndromic Disorders with Short Stature
por: Şıklar, Zeynep, et al.
Publicado: (2014)

Current Status of Childhood Hyperinsulinemic Hypoglycemia in Turkey
por: Şıklar, Zeynep, et al.
Publicado: (2016)

SUN-032 Digenic Inheritance of PCSK1 and CHD7 Mutations in PAX4 Homozygous Diabetic Male with Normosmic Hypogonadotropic Hypogonadism
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Expert opinion on patient journey, diagnosis and clinical monitoring in acid sphingomyelinase deficiency in Turkey: a pediatric metabolic disease specialist's perspective
por: Arslan, Nur, et al.
Publicado: (2023)

Prospective Follow-up of Children with Idiopathic Growth Hormone Deficiency After Termination of Growth Hormone Treatment: Is There Really Need for Treatment at Transition to Adulthood?
por: Çamtosun, Emine, et al.
Publicado: (2018)

Serum IGF-1 and IGFBP-3 Levels in Healthy Children Between 0 and 6 Years of Age
por: Yüksel, Bilgin, et al.
Publicado: (2011)

Expert-opinion-based guidance for the care of children with lysosomal storage diseases during the COVID-19 pandemic: An experience-based Turkey perspective
por: Akgun, Abdurrahman, et al.
Publicado: (2023)

Mutations Within the Transcription Factor PROP1 in a Cohort of Turkish Patients with Combined Pituitary Hormone Deficiency
por: Bulut, Fatma Derya, et al.
Publicado: (2020)

The Effect of Recombinant Growth Hormone Treatment in Children with Idiopathic Short Stature and Low Insulin-Like Growth Factor-1 Levels
por: Şıklar, Zeynep, et al.
Publicado: (2015)

Selective Hole Filling of Red Blood Cells for Improved Marker-Controlled Watershed Segmentation
por: Nurçin, Fatih Veysel, et al.
Publicado: (2021)

The Role of American Thyroid Association Pediatric Thyroid Cancer Risk Stratification and BRAF(V600E) Mutation in Predicting the Response to Treatment in Papillary Thyroid Cancer Patients ≤18 Years Old
por: Giles Şenyürek, Yasemin, et al.
Publicado: (2022)

Two Families with Normosmic Congenital Hypogonadotropic Hypogonadism and Biallelic Mutations in KISS1R (KISS1 Receptor): Clinical Evaluation and Molecular Characterization of a Novel Mutation
por: Brioude, Frédéric, et al.
Publicado: (2013)

Combined Evaluation of IGF−1 and IGFBP−3 as an Index of Efficacy and Safety in Growth Hormone Treated Patients
por: Şıklar, Zeynep, et al.
Publicado: (2009)

Childhood Sustained Hypercalcemia: A Diagnostic Challenge
por: Çullas İlarslan, Nisa Eda, et al.
Publicado: (2017)

Evaluation of Efficacy of Long-term Growth Hormone Therapy in Patients with Hypochondroplasia
por: Çetin, Tuğba, et al.
Publicado: (2018)

The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway
por: Şıklar, Zeynep, et al.
Publicado: (2020)

Central Precocious Puberty in an Infant with Sotos Syndrome and Response to Treatment
por: Kontbay, Tuğba, et al.
Publicado: (2022)

Hypophyseal Dysfunction and Difficulties in Management of Pediatric Intracranial Germ Cell Tumors
por: İsakoca, Mehmet, et al.
Publicado: (2022)

Current Practice in Diagnosis and Treatment of Growth Hormone Deficiency in Childhood: A Survey from Turkey
por: Poyrazoğlu, Şükran, et al.
Publicado: (2015)

The Effect of Growth Hormone Therapy on Cardiac Outcomes in Noonan Syndrome: Long Term Follow-up Results
por: Kızılcan Çetin, Sirmen, et al.
Publicado: (2022)

ROHHAD Syndrome: Reasons for Diagnostic Difficulties in Obesity
por: Kocaay, Pınar, et al.
Publicado: (2014)

Delayed Diagnosis of a 17-Hydroxylase/17,20-Lyase Deficient Patient Presenting as a 46,XY Female: A Low Normal Potassium Level Can Be an Alerting Diagnostic Sign
por: Çamtosun, Emine, et al.
Publicado: (2017)

Machine learning and statistical methods for the prediction of maximal oxygen uptake: recent advances
por: Abut, Fatih, et al.
Publicado: (2015)

Nationwide Turkish Cohort Study of Hypophosphatemic Rickets
por: Şıklar, Zeynep, et al.
Publicado: (2020)

Efficiency of Fluid Treatments with Different Sodium Concentration in Children with Type 1 Diabetic Ketoacidosis
por: Savaş-Erdeve, Şenay, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3jrt2k8t9umr1u5amh7u1mc02l